Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

35 results about "Acinus" patented technology

An acinus (/ˈæsɪnəs/; plural, acini; adjective, acinar /ˈæsɪnər/ or acinous) refers to any cluster of cells that resembles a many-lobed "berry", such as a raspberry (acinus is Latin for "berry"). The berry-shaped termination of an exocrine gland, where the secretion is produced, is acinar in form, as is the alveolar sac containing multiple alveoli in the lungs.

Application of sodium butyrate in prevention and treatment of cow mastitis

The invention discloses application of sodium butyrate to prevention and treatment of dairy cow mastitis, and belongs to the technical field of biology. The invention can provide an application of sodium butyrate in preventing and treating cow mastitis, in particular an application in preparing a preparation for preventing and treating cow mastitis induced by lipopolysaccharide (LPS) in escherichia coli. According to the application of the sodium butyrate in the aspect of preventing and treating the dairy cow mastitis, expression of key factors such as mammary gland tight junction protein is up-regulated under stimulation of lipopolysaccharide (LPS), and the sodium butyrate can effectively inhibit apoptosis and enhance the barrier function of mammary gland acinus, so that the effect of preventing and treating the dairy cow mastitis is achieved.
Owner:HENAN AGRICULTURAL UNIVERSITY

Lactobacillus paracasei CFCFC018, microbial inoculum and application of lactobacillus paracasei CFCFC018

The invention discloses lactobacillus paracasei CFCFC018, a microbial agent and application of the lactobacillus paracasei CFCFC018, and belongs to the technical field of microorganisms. The lactobacillus paracasei CFCFC018 is separated from intestinal contents of rural cats in half-farming and half-pastoral areas in Inner Mongolia, does not need genetic engineering modification, can highly express amino acids and neurotransmitters, can remarkably relieve mammary gland alveolar structure damage in mammary gland tissues of rats suffering from mastitis induced by staphylococcus aureus, and has the advantages of being high in safety and good in stability. The thickening of a mammary gland interacellular matrix layer is avoided, the infiltration number of neutrophils is reduced, the damage degree of mammary gland tissues is reduced, and a certain protection effect on the mammary gland tissues is achieved. The research also shows that the strain can reduce the abundance of harmful bacteria in excrement, improve intestinal inflammation and relieve edema of intestinal submucosa, which provides a new thought for preventing and treating mastitis by regulating intestinal microbiota.
Owner:JILIN AGRICULTURAL UNIV

Application of medicine for intervening mitochondrial pyruvic acid carrier in preparation of medicine for treating acute pancreatitis and medicine composition of medicine for intervening mitochondrial pyruvic acid carrier

The invention belongs to the field of biological medicines, and particularly relates to application of a medicine for intervening in a mitochondrial pyruvic acid carrier in preparation of a medicine for treating acute pancreatitis and a medicine composition of the medicine. The medicine for intervening in the mitochondrial pyruvic acid carrier can reduce the serum enzyme level, relieve pancreatic pathological injury, inhibit inflammatory response, inhibit calcium overload and protect the mitochondrial function, so that pancreatic acinus cell injury is relieved, the effect of treating acute pancreatitis is achieved, and the medicine has a wide application prospect. The invention provides a new choice for clinically treating acute pancreatitis, and has a good application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Compounds for the reducing lipotoxic damage

PendingUS20250340512A1Organic active ingredientsAntibacterial agentsCulture negativeLipase inhibitors
Provided herein are novel lipase inhibitors and methods for using the same to treat inflammation, multisystem organ failure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis (e.g., culture negative sepsis), burns, and acne. For example, provided herein are two novel lipase inhibitors useful in the methods described herein:or a pharmaceutically acceptable salt thereof.
Owner:MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

Application of dimethyl fumarate in preparation of medicine for treating hypertriglyceridemia acute pancreatitis

The invention provides an application of dimethyl fumarate in preparation of a medicine for treating hypertriglyceridemia type acute pancreatitis. Experiments prove that the dimethyl fumarate can treat the hypertriglyceridemia acute pancreatitis, and specifically, the dimethyl fumarate can relieve pancreatic tissue edema of the hypertriglyceridemia acute pancreatitis, relieve pancreatitis infiltration, relieve pancreatic acinus necrosis and the like. The invention provides a new strategy for treating hypertriglyceridemia acute pancreatitis, and has a good clinical application prospect.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL

Pancreatic exocrine function in-vivo monitoring system and monitoring method

According to the pancreas exocrine function in-vivo high-resolution monitoring system and monitoring method provided by the invention, exciting light emitted by a laser module (1) is reflected by a scanning galvanometer (21) and then is transmitted through a dichroscope (22); the femtosecond pulse exciting light passing through the dichroscope (22) is focused on a pancreas sample arranged on the objective table (24) by the objective lens (23) and excites a tryptophan two-photon fluorescence signal in the pancreas sample, and the tryptophan two-photon fluorescence signal is collected by the objective lens (23); after being reflected by the dichroscope (22), the femtosecond pulse exciting light is separated from the femtosecond pulse exciting light and then detected by the detector (25), so that a two-photon fluorescence image of tryptophan in the pancreatic sample is obtained, and tryptophan two-photon fluorescence can display pancreatic adenosine zymogen particles. The tryptophan two-photon fluorescence signal is used for carrying out delayed dynamic imaging on a pancreas sample, so that in-vivo, three-dimensional and high-resolution characterization of the pancreas zymogen particle number, distribution polarity, movement tendency and other characteristics can be reflected, and the pancreas exocrine function of the organism can be reflected in real time.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Single-cell suspension for increasing ratio of pancreatic acinus cells and preparation method of single-cell suspension

The invention provides a single-cell suspension for increasing the ratio of pancreatic acellular cells and a preparation method of the single-cell suspension. The preparation method comprises the following steps: taking materials; a collagenase digestion step: performing mixed digestion on the small pancreas blocks and a collagenase dissociation liquid, and collecting acinus cells through gradient centrifugal separation; and a single cell separation step: dispersing the alveolar cells into single cells by using the recombinant trypsin substitute. The collagen enzyme dissociation liquid in a specific combination is adopted, cold digestion is not needed, and digestion can be completed within 30 minutes; a gradient centrifugation mode is adopted to separate the acinus cells, so that the purity of target cells is improved; when the recombinant trypsin substitute is used for single cell separation, single cells can be rapidly and efficiently obtained, and repeated filtration is not needed. Besides, the cell viability of the mouse pancreas single-cell suspension obtained by the method is higher than 90%, the proportion of acinus cells reaches 70% or above, and a high-quality cell sample is provided for subsequent experimental research.
Owner:THE FIRST AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY OF CHINESE PEOPLES LIBERATION ARMY

Use of paeoniflorin-6'-o-benzenesulfonate for improving acinar atrophy

The present application relates to the field of pharmacology, in particular to the use of paeoniflorin-6'-O-benzene sulfonate for improving acinar atrophy, maintaining the stability of gland functional units, and repairing gland secretion function. The paeoniflorin-6'-O-benzene sulfonate can effectively improve the acinar atrophy of diabetic animals, and the effect is significantly better than that of paeoniflorin, and can be used for preparing a medicine for treating xeroma.
Owner:GUANGZHOU HANFANG PHARMA CO LTD

Use of creld2 in the preparation of a medicament for treating acute pancreatitis

PendingCN122643472AAcinar cellPharmaceutical drug
The application belongs to the technical field of biotechnology, and discloses application of CRELD2 in preparation of a drug for treating acute pancreatitis. The application constructs Creld2 gene knockout mice and pancreas acinar cell specific Creld2 overexpression mice, and uses caerulein to induce an acute pancreatitis model, so as to clarify the functional role of the Creld2 gene in the caerulein-induced acute pancreatitis, and to prove that Creld2 gene knockout can aggravate pancreas injury, and pancreas acinar cell specific overexpression of Creld2 can reduce pancreas injury. Through the two-way evidence of gene knockout aggravating pancreas injury and gene overexpression reducing pancreas injury, it is firstly proved that CRELD2 has a protective effect on the caerulein-induced acute pancreatitis, and a new strategy for intervention of acute pancreatitis based on CRELD2 is provided.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

?-lactone lipase inhibitors for reducing lipotoxic damage

ActiveCA3069526CCulture negativeLipase inhibitors
Provided herein are novel lipase inhibitors and meth- ods for using the same to treat inflammation, multisystem organ fail- ure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis (e.g., culture negative sepsis), burns, and acne. For example, provid- ed herein are two novel lipase inhibitors useful in the methods de- scribed herein: (I) (II) or a pharmaceutically acceptable salt thereof.
Owner:MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

N-(quinazoline-4-yl) benzo [d] thiazole-5-amine RIPK2 degradation agent

PendingCN121471211AOrganic active ingredientsNervous disorderDiseasePancreas Ductal Adenocarcinoma
The invention discloses an N-(quinazoline-4-yl) benzo [d] thiazole-5-amine RIPK2 degradation agent and application of the N-(quinazoline-4-yl) benzo [d] thiazole-5-amine RIPK2 degradation agent, and belongs to the field of medicines. The structural general formula of the N-(quinazoline-4-yl) benzo [d] thiazole-5-amine RIPK2 degradation agent provided by the invention is shown as a formula (I), and the compound comprises an acceptable salt of the N-(quinazoline-4-yl) benzo [d] thiazole-5-amine RIPK2 degradation agent. The N-(quinazoline-4-yl) benzo [d] thiazole-5-amine compound disclosed by the invention has relatively good proliferation inhibition activity on pancreatic cancer cells, shows obvious degradation activity on RIPK2 protein, and is relatively high in safety. Therefore, the compound can be applied to preparation of medicines for treating various RIPK2-mediated diseases, including but not limited to pancreatic ductal adenocarcinoma, pancreatic acicular cell carcinoma and pancreatic neuroendocrine tumor.
Owner:ZHEJIANG UNIV

Application of exogenous pancreatic acellular cell ALDH2 to preparation of medicine or health care product for preventing or treating acute pancreatitis

The invention provides a new application of exogenous pancreatic acinus cell ALDH2 in preparation of drugs or health care products for preventing or treating acute pancreatitis. Experiments prove that on a mouse acute pancreatitis model, after pancreatic acinus cell ALDH2 expression is specifically knocked out, the pancreatic tissue damage degree is increased, and the pancreatic tissue inflammation infiltration degree is increased; the levels of AMY and LPS reflecting the severity of acute pancreatitis and the overall inflammation level in mouse serum are increased; the level of NLRP3 inflammasome closely related to occurrence and development of acute pancreatitis in pancreatic tissue is remarkably increased, and the results show that the pancreatic acellular cell ALDH2 protein has a protective effect on the severity and prognosis of acute pancreatitis.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

Compounds for the reducing lipotoxic damage

ActiveUS12325690B2Organic active ingredientsAntibacterial agentsCulture negativeLipase inhibitors
Provided herein are novel lipase inhibitors and methods for using the same to treat inflammation, multisystem organ failure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis (e.g., culture negative sepsis), burns, and acne. For example, provided herein are two novel lipase inhibitors useful in the methods described herein:or a pharmaceutically acceptable salt thereof.
Owner:MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

Application of indole-3-lactic acid in preparation of medicine for resisting acute pancreatitis

The invention relates to application of indole-3-lactic acid in preparation of an acute pancreatitis resisting medicine, and belongs to the technical field of medicines. The invention provides an application of indole-3-lactic acid in preparation of an acute pancreatitis resisting medicine. An antibiotic mixture is used for conducting intragastric administration on a mouse, intestinal bacteria are removed, ILA and STS are subjected to intragastric administration on the mouse, leptofrog and arginine are injected into the abdominal cavity of the mouse for acute pancreatitis modeling, the acute pancreatitis resisting effect of ILA is studied, and the result shows that the amylase concentration in serum of the mouse subjected to intragastric administration of ILA is remarkably reduced; compared with STS, the ILA has the advantages that pancreatic tissue alveolar cell damage and inflammatory infiltration are obviously reduced, inflammatory cytokines in pancreatic tissue and serum are obviously reduced, and compared with STS, the ILA has a better protection effect, so that the ILA has the effect of resisting acute pancreatitis, and a new treatment way is provided for preventing and treating acute pancreatitis.
Owner:ZHEJIANG UNIV

Application of L.massiosenegalense and phenyllactic acid produced by L.massiosenegalense in preparation of medicine for preventing and treating acute pancreatitis

PendingCN120919176AOrganic active ingredientsDigestive systemCytokinePancreas Inflammation
The invention provides application of L.massiosenegalense and phenyllactic acid generated by the L.massiosenegalense in preparation of a medicine for preventing and treating acute pancreatitis, and belongs to the technical field of biological medicine. The L.massiosenegalense and the phenyllactic acid produced by the L.massiosenegalense can prevent and treat acute pancreatitis, relieve alveolar cell injury and inflammatory cell infiltration caused by acute pancreatitis, and reduce amylase concentration in serum and transcription and expression of inflammatory cytokines in pancreas and serum.
Owner:ZHEJIANG UNIV

A nanomedicine for targeted treatment of acute pancreatitis and its preparation method and application

The present invention belongs to the field of biotechnology, and specifically relates to a nano drug for targeted treatment of acute pancreatitis, and a preparation method and application thereof. It includes an inorganic nano material loaded with a trypsin inhibitor and a calcium ion chelator, and a cell membrane of an immune cell with the ability to recruit at the inflammatory site is wrapped in its outer layer, and a structure with the ability to target pancreatic acinar cells is inserted into the cell membrane. In the mouse acute pancreatitis model, the nano drug of the present invention can realize the active recruitment of inflammatory endothelium, transendothelial migration, and precise targeting of acinar cells at the lesion site, avoid immune clearance, and prolong the circulation time. Through the carefully planned drug release, the efficient elimination of calcium overload and the ingenious combination of inhibiting trypsin activity are cleverly combined, and the source of downstream acinar cell apoptosis and necrosis events is fundamentally blocked, and multi-mechanism regulation is achieved in the complex and changeable inflammatory environment of the pancreatic lesion site, and the therapeutic effect is maximized, which has high potential and application prospects in the treatment of acute pancreatitis.
Owner:OCEAN UNIV OF CHINA

Application of chrysin in preparation of medicine for treating primary sjogren's disease

The application discloses application of chrysin in preparation of a medicine for treating primary Sjogren's syndrome and belongs to the technical field of biological medicine. The application proves that chrysin can be specifically combined with TNFR2 protein and is a new type of TNFR2 inhibitor through molecular docking, molecular dynamics simulation, CETSA experiment and SPR experiment. Animal experiments show that chrysin can significantly increase the secretion amount of saliva and tear of a mouse model of primary Sjogren's syndrome, reduce the serum SSA and SSB antibody levels, reduce lymphocyte infiltration and acinus atrophy of submandibular glands and lacrimal glands, inhibit the expression of a cytokine INF-gamma, and the drug efficacy is equivalent to that of a positive medicine hydroxychloroquine; chrysin and gaoshunyujin have a synergistic effect, and the improvement effect on primary Sjogren's syndrome is better than that of hydroxychloroquine. The application provides a new medical use of chrysin, and provides a safe and effective prevention and treatment medicine for primary Sjogren's syndrome.
Owner:ZHEJIANG ACAD OF TRADITIONAL CHINESE MEDICINE

Method for simultaneously extracting various cells of internal and external secretion parts of pancreas

PendingCN121249562AVertebrate cellsArtificial cell constructsDigestionType-II alveolar cell
The invention discloses a method for simultaneously extracting various cells of internal and external secretion parts of pancreas, and relates to the technical field of pancreas islet separation and purification. The invention discloses a method for simultaneously extracting various cells of internal and external secretion parts of pancreas. The method comprises the following steps: exposing a target visual field, performing pancreas perfusion, terminating digestion, sieving, performing gradient centrifugation, observing and separating layered cells, sorting pancreas islets, extracting acinus cells and identifying. According to the method, a gradient centrifugation method is adopted, a density gradient environment is constructed through a gradient centrifugation solution based on the difference of different cell densities, and various cells settle to corresponding positions according to self densities, so that efficient separation of islet cells, alveolar cells and impurities (such as adipocytes, digestive enzymes and tissue fragments) is realized, and the separation efficiency of the islet cells, the alveolar cells and the impurities is improved. Finally, different types of cells are obtained, and various cell populations obtained based on the method are high in purity, good in activity and high in yield.
Owner:THE SECOND AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY PLA

Allicular simulation three-dimensional scaffold material for regeneration and repair of salivary glands as well as preparation method and application of alveolar simulation three-dimensional scaffold material

PendingCN119055837APromote recruitmentAchieve recruitmentAdditive manufacturing apparatusProsthesisCell-Extracellular MatrixFreeze-drying
The invention belongs to the field of biomedical engineering, and particularly relates to an acinus-imitating three-dimensional scaffold material for regeneration and repair of salivary glands as well as a preparation method and application of the acinus-imitating three-dimensional scaffold material for regeneration and repair of salivary glands, and the acinus-imitating three-dimensional scaffold material comprises 0.01-9.5% of astragalus polysaccharide, 35-90% of silk fibroin and 10-40% of collagen. The preparation process comprises the following steps: forming the material through low-temperature 3D printing, preparing macroscopic pores among wire harnesses, removing water in the material through a freeze drying method, forming microcosmic pores in the wire harnesses, dissolving astragalus polysaccharide in water, adsorbing the astragalus polysaccharide on a dry bracket, and freeze-drying again to form uniform load of the medicine. The micropore structure is similar to the acinus, a space is provided for ordered growth of cells, the macroscopic pores achieve the function of a conveying channel, and a multi-dimensional and multifunctional pore structure is prepared. The fibroin collagen provides an extracellular matrix framework for salivary gland regeneration, the performance of the stent is enhanced by utilizing the multi-effect promotion effect of the astragalus polysaccharide on cells, and the stent has good functions of resisting inflammation, promoting salivary secretion and local tissue regeneration and is suitable for parotid gland defect repair.
Owner:TIANJIN DENTAL HOSPITAL

Application of purple rice seed coat extract in preparing medicine for preventing and treating acute pancreatitis

The invention discloses a new application of a purple rice seed coat extract in the preparation of a drug for preventing and treating acute pancreatitis, and belongs to the field of biomedicine technology. The purple rice seed coat extract of the invention is used to prepare a drug for preventing and treating acute pancreatitis, which broadens the application field of the purple rice seed coat and provides a new choice and idea for preventing and treating acute pancreatitis; the animal model of acute pancreatitis induced by caerulein is used to confirm the effect of the purple rice seed coat extract in reducing serum amylase, lipase and the expression of MPO and SOD in plasma, alleviating pancreatic tissue damage, acinar cell vacuoles and inflammatory cell infiltration, reducing the expression of pancreatic tissue inflammation and oxidative stress-related factors, and reducing pancreatitis-related intestinal permeability.
Owner:KUNMING UNIV OF SCI & TECH

Use of high-density lipoprotein in the preparation of a medicament for treating acute pancreatitis

The present invention discloses the use of high-density lipoprotein in the preparation of a medicament for preventing or treating acute pancreatitis. The medicament for treating acute pancreatitis provided by the present invention contains high-density lipoprotein, which can effectively reduce the inflammatory response, inflammatory cell infiltration and necrosis of pancreatic acinar cells in patients with acute pancreatitis. The medicament for treating acute pancreatitis provided by the present invention contains high-density lipoprotein, which can selectively accumulate in the pancreatic tissue of patients with acute pancreatitis. High-density lipoprotein not only has the effect of treating acute pancreatitis itself, but also high-density lipoprotein-related nano-biological preparations can be used to carry other anti-inflammatory drugs for targeted treatment of acute pancreatitis, having good clinical application prospects.
Owner:FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV

Application of Amuc1409 protein in prevention and treatment of acute pancreatitis

The invention relates to the field of biological medicines, and provides application of Amuc1409 protein in prevention and treatment of acute pancreatitis. When the Amuc1409 protein is used for preventing or treating acute pancreatitis, the Amuc1409 protein plays a role through at least one of the following ways: (1) reducing the amylase concentration in serum; (2) relieving acinus cell injury and inflammatory cell infiltration; (3) reducing transcription of inflammatory cytokines in pancreas; and (4) increasing the proportion of regulatory T cells in peripheral blood lymphocytes. The invention discovers and verifies the effect of Ackermann secretory protein Amuc1409 in the aspect of preventing and treating acute pancreatitis for the first time, and the prevention and treatment effect is superior to that of Ackermann membrane protein Amuc1100.
Owner:ZHEJIANG UNIV

Application of phellodendrine in preparation of medicine for preventing and / or treating acute pancreatitis

The invention discloses application of phellodendrine in preparation of a medicine for preventing and / or treating acute pancreatitis, and belongs to the technical field of biological medicine. The invention discloses a key link in acute pancreatitis pathogenesis that phellodendrine directly acts on neutrophil-mediated excessive inflammatory response and upstream regulation of extracellular trap formation (NETs) for the first time, and reduces the generation of active oxygen by inhibiting the generation of neutrophil extracellular traps of pancreatic tissues, thereby reducing the damage degree of acinus cells. As a small molecule compound, phellodendrine has better tissue permeability and metabolic stability. Compared with a synthetic NETs inhibitor, the natural product has more advantages in the aspect of reducing immunotoxicity. Therefore, the invention proves that the phellodendrine (PHE) realizes the effects of relieving the inflammatory response of the acute pancreatitis and reducing the severity of the acute pancreatitis by targeting immune cells (inhibiting the formation of extracellular traps of neutrophils).
Owner:YANGZHOU FIRST PEOPLES HOSPITAL

Feed for rapidly inducing high fat pancreatitis model mouse construction

The invention discloses a feed for rapidly inducing high-fat pancreatitis model mouse construction. The feed is prepared by taking ethionine and sodium taurocholate as core inducers, lard and palm oil as basic lipids and cholesterol as a lipid regulator. Wherein the mass ratio of the ethionine to the sodium taurocholate is 3: 5. According to the present invention, by optimizing the ratio of lipid to the inducer to the synergistic component, the new feed formula for constructing the high-fat pancreatitis model mouse is obtained, the high-fat pancreatitis model mouse can be efficiently and stably constructed, and the obtained model mouse can simultaneously show lipid infiltration, acinus pyroptosis and inflammatory factor release, the traditional Chinese medicine composition accords with the multi-strike characteristic of clinical high-fat pancreatitis.
Owner:FUJIAN ACAD OF MEDICAL SCI

Application of gold-derived tricarboxylic acid in the preparation of drugs for Staphylococcus aureus mastitis

PendingCN123059029AAntibacterial agentsOrganic active ingredientsBiotechnologyAurintricarboxylic acid
This invention relates to the field of biomedical technology, and discloses the application of gold-derived tricarboxylic acid in the preparation of drugs for Staphylococcus aureus mastitis. This invention discovers that gold-derived tricarboxylic acid can inhibit the hemolytic activity mediated by Staphylococcus aureus α-toxin and / or β-toxin, reduce Staphylococcus aureus-induced ferroptosis in mammary epithelial cells, and decrease intracellular reactive oxygen species and Fe. 2+ This invention reduces lipid peroxide levels and improves mitochondrial damage; it also alleviates inflammatory cell infiltration and acinar structure destruction in breast tissue. This invention provides a novel pharmaceutical application for the treatment of Staphylococcus aureus mastitis.
Owner:JILIN UNIVERSITY

Silicon ion preparation for treating chronic pancreatitis, and preparation method and application thereof

The application belongs to the technical field of biological medicine, and particularly relates to a silicon ion preparation for treating chronic pancreatitis and a preparation method and application thereof. The silicon ion preparation has excellent effects of promoting regeneration of pancreatic acinar cells and inhibiting inflammation and fibrosis of pancreatic tissue. The silicon mineral preparation prepared according to the concentration can be used for treating chronic pancreatitis and preventing fibrosis, and has great application prospects. The silicon ion preparation provided in the embodiment can treat chronic pancreatitis and prevent fibrosis. The active material can significantly treat the activity of pancreatitis cells, so as to form healthy pancreatic tissue. The silicon ion preparation comprises that the concentration of silicon ions in the silicon ion preparation is 5 ppm-800 ppm, and the silicon ion preparation is prepared by releasing silicon ions from a silicon mineral preparation.
Owner:WENZHOU INST UNIV OF CHINESE ACAD OF SCI

Application of Trem2 in preparation of medicine for treating and / or preventing acute pancreatitis

The invention relates to the technical field of biological medicine, in particular to application of Trem2 in preparation of medicine for treating and / or preventing acute pancreatitis. Aiming at the internal relation among Trem2, autophagy and pyroptosis of acellular cells in acute pancreatitis, intervention is carried out through targeting Trem2, the autophagy function can be accurately adjusted, pyroptosis of acellular cells can be inhibited, compared with a traditional non-specific treatment method, higher pertinence and effectiveness are achieved, and the treatment effect can be remarkably improved.
Owner:XUANWU HOSPITAL OF CAPITAL UNIV OF MEDICAL SCI

Application of organic lycium barbarum polysaccharide in prevention and treatment of pancreatic acinar ductal metaplasia

PendingCN122624515AMetaplasiaIn vivo experiment
The application belongs to the biological field and particularly relates to application of organic medlar polysaccharide in prevention and treatment of pancreatic acinar ductal metaplasia. Through in-vivo animal experiments, it is found that compared with common medlar polysaccharide, the organic medlar polysaccharide can significantly reduce the pancreatic acinar ductal metaplasia lesion area, can be used as a natural preparation for preventing pancreatic acinar ductal metaplasia, effectively improves the pancreatic acinar ductal metaplasia, and is used for reducing the incidence and progress risk of the pancreatic acinar ductal metaplasia.
Owner:LANZHOU UNIV SECOND HOSPITAL +1

Method for establishing model of hamster injection sodium taurocholate induced acute pancreatitis

InactiveCN120323402AFood processingVeterinary instrumentsCholic acidGolden hamster
The invention provides a method for establishing a model for injecting sodium taurocholate into hamsters to induce acute pancreatitis, which comprises the following operation steps: S1, selecting 4-week-old naria golden hamsters with the weight of 70-80g, and continuously feeding the hamsters with high-fat feed for 28 days. The invention provides a method for establishing a model for injecting sodium taurocholate to induce acute pancreatitis in hamsters, which comprises the following steps of: continuously feeding the narian golden hamsters with high-fat feed for 28 days, measuring the serum triglyceride level through venous plexus blood sampling, confirming that the hypertriglyceridemia exists, and simultaneously injecting sodium taurocholate into the main pancreatic duct to induce acute pancreatitis through puncturing the main pancreatic duct, so that the acute pancreatitis induced by injecting sodium taurocholate to the narian golden hamsters is induced. A 7% sodium taurocholate solution is injected to establish a hypertriglyceridemia acute pancreatitis model, so that metabolic disorder is pre-induced through high fat diet, the pathologic basis of human hypertriglyceridemia is simulated, pancreatic acinus cells are directly damaged by retrograde injection of sodium taurocholate into pancreatic ducts, and the hypertriglyceridemia acute pancreatitis model is obtained. And the disease course of human hypertriglyceridemia acute pancreatitis is accurately represented by dual mechanisms.
Owner:CHANGZHOU YANYI MEDICAL TECH CO LTD